TENET HEALTHCARE CORP THC Income Statement

Tenet healthcare corp (THC)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Sep'09	Jun'09
Revenues
18,454	18,479	18,292	18,213	18,159	18,313	18,672	18,769	19,065	19,179	19,061	19,324	19,390	19,621	19,787	19,630	19,254	18,634	18,072	17,555	17,101	16,603	14,547	0	0	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Net operating revenues:
Net operating revenues before provision for doubtful accounts
-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	9,588	9,433	9,371	0	0	0	-	-	-	-	-	-
Less: Provision for doubtful accounts
-	-	-	-	-	-	-	-	-	1,434	1,463	1,475	1,456	1,449	1,486	1,490	1,490	1,477	1,442	1,320	1,288	1,305	1,297	1,258	1,145	972	824	820	803	785	766	749	727	717	714	712	717	727	742	722	0	0	0
Net operating revenues before provision for doubtful accounts
-	-	-	-	-	-	-	-	-	-	-	-	20,846	-	21,273	21,120	20,744	20,111	19,514	18,875	18,389	17,908	17,720	15,914	13,978	12,059	10,337	10,146	9,989	9,904	9,166	8,839	8,706	8,654	7,843	8,005	8,176	8,265	9,166	9,133	0	0	0
Income (Loss) from Equity Method Investments
169	175	167	162	159	150	146	151	140	144	141	134	136	131	136	133	119	99	52	28	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating expenses:
Salaries, wages and benefits
8,740	8,704	8,629	8,571	8,558	8,634	8,762	8,910	9,121	9,274	9,306	9,350	9,313	9,328	9,434	9,384	9,260	8,990	8,686	8,456	8,227	8,023	7,777	6,921	6,131	5,371	4,590	4,468	4,356	4,257	4,180	4,132	4,060	4,015	3,898	3,873	3,860	3,830	3,887	3,859	0	0	0
Supplies
3,079	3,057	3,010	2,976	2,971	3,004	3,048	3,062	3,094	3,085	3,058	3,085	3,078	3,124	3,168	3,153	3,087	2,963	2,834	2,747	2,689	2,630	2,568	2,290	2,028	1,784	1,546	1,535	1,537	1,552	1,545	1,548	1,551	1,548	1,526	1,537	1,540	1,542	1,572	1,577	0	0	0
Other operating expenses, net
4,137	4,189	4,226	4,278	4,261	4,256	4,276	4,302	4,434	4,561	4,671	4,782	4,836	4,891	4,916	4,836	4,704	4,555	4,373	4,254	4,208	4,114	4,057	3,600	3,132	2,701	2,253	2,217	2,184	2,147	2,098	2,086	2,060	2,020	1,913	1,891	1,881	1,857	1,956	1,923	0	0	0
Electronic health record incentives
-	-	3	3	-	-	2	3	9	-	10	30	0	-	0	0	-	72	-78	-76	-101	-104	-120	-129	-105	-96	-61	-47	0	-	0	0	-	-55	0	0	0	-	-	-	-	-	-
Depreciation, Depletion and Amortization
845	850	827	826	806	802	810	825	853	870	880	866	859	850	840	820	802	797	829	851	863	849	800	712	624	545	470	461	444	430	414	404	400	398	385	386	383	380	390	387	0	0	0
Restructuring Settlement Impairment Provisions and Acquisition Cost
221	185	187	187	181	209	261	544	555	541	524	226	207	202	133	146	317	318	329	322	161	153	148	131	110	103	52	38	30	19	14	16	15	20	27	22	18	10	8	6	0	0	0
Gain (Loss) Related to Litigation Settlement
-130	-141	-125	-50	-45	-38	-39	-36	-24	-23	-14	-12	-125	-293	-515	-561	-461	-291	-73	-27	-25	-25	-47	-44	-34	-31	-5	-4	-3	-5	-34	-39	-46	-55	-30	-27	-21	-12	-9	-16	0	0	0
Net Gain on Sale, Consolidation, And Deconsolidation Of Facilities
-12	-15	13	7	16	127	113	224	239	144	142	41	19	151	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating income
1,459	1,513	1,467	1,493	1,511	1,647	1,728	1,459	1,363	1,113	908	1,196	1,160	1,247	1,303	1,251	1,141	1,077	1,078	1,002	1,045	925	755	692	687	663	707	712	690	749	693	619	604	653	663	681	687	634	602	643	0	0	0
Interest expense
977	985	988	993	1,000	1,004	1,011	1,019	1,025	1,028	1,024	1,010	994	979	978	983	956	912	860	798	771	754	740	645	553	474	401	413	417	412	403	359	355	375	376	424	433	424	435	448	0	0	0
Other non-operating expense, net
5	5	10	7	7	5	36	32	26	22	24	21	21	20	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from early extinguishment of debt
-180	-227	-224	-44	-45	1	-2	-140	-165	-164	-164	-26	0	-	0	0	-	-	-	-	-	-	0	-	-	-348	-352	-352	-181	-4	0	0	0	-	-	-	-	-	0	-	-	0	0
Investment earnings
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	0	-	1	2	2	3	3	3	5	5	5	7	-1	0	0	0
Income from continuing operations, before income taxes
297	296	249	453	463	639	705	286	155	-101	-296	141	147	248	286	237	158	144	218	179	250	147	-9	47	-36	-158	-46	-52	92	334	175	145	135	164	288	205	202	158	103	172	0	0	0
Net gain on sales of investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Income tax benefit (expense)
58	153	126	112	126	176	444	378	322	219	-99	-29	-33	67	129	130	119	68	60	31	66	49	-19	15	-13	-65	-22	-20	30	125	78	64	53	61	75	-931	-930	-977	-976	30	0	0	0
Income from continuing operations, before discontinued operations
239	143	123	341	337	463	261	-92	-167	-320	-197	170	180	181	157	107	39	76	158	148	184	98	10	32	-23	-93	-24	-32	62	209	97	81	82	103	213	1,136	1,132	1,135	1,079	142	0	0	0
Discontinued operations:
Income (loss) from operations
4	15	14	13	13	4	4	3	3	0	-2	1	-3	-6	-6	-9	-9	-5	-4	-5	-10	-17	-17	-23	-10	-5	-14	-2	-7	-2	6	0	-6	-18	-2	-4	-4	11	-6	-13	0	0	0
Litigation and investigation benefit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	-	-	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of long-lived assets and goodwill
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	1	2	9	0	0	0
Net gains on sale of facilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-	-	0	0
Income tax expense
2	4	3	3	3	1	0	0	1	0	-1	0	-1	-1	0	0	0	-	-	-1	-9	-13	-6	-10	2	4	-4	5	-27	-25	-32	-36	-26	-32	-31	-34	-13	-7	2	5	0	0	0
Income (loss) from discontinued operations
2	11	11	10	10	3	4	3	2	0	-1	1	-2	-5	-2	-4	-3	2	-1	-1	-16	-22	-29	-33	-14	-11	-12	-8	-79	-76	-84	-85	-3	-9	29	31	7	17	-10	-27	0	0	0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
241	154	134	351	347	466	265	-89	-165	-320	-198	171	178	176	155	103	36	78	157	147	168	76	-19	-1	-37	-104	-36	-40	-17	133	13	-4	79	94	242	1,167	1,139	1,152	1,069	115	0	0	0
Less: Net income available to noncontrolling interests
368	386	366	360	347	355	378	382	387	384	356	366	364	368	365	334	282	218	139	91	77	64	54	53	41	30	0	0	0	-	-	-	0	-	0	0	0	-	9	8	0	0	0
Less: Preferred stock dividends
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11	17	22	24	24	24	24	24	24	18	12	0	0	0
Continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Net income available (loss attributable) to Tenet Healthcare Corporation common shareholders
-127	-232	-232	-9	0	111	-113	-471	-552	-704	-554	-195	-186	-192	-210	-231	-246	-140	18	56	91	12	-73	-54	-78	-134	-61	-49	-5	141	16	-18	43	58	208	1,134	1,104	1,119	1,042	95	0	0	0
Amounts available (attributable) to Tenet Healthcare Corporation common shareholders
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent
-129	-243	-243	-19	-10	108	-117	-474	-554	-704	-553	-196	-184	-187	-208	-227	-243	-142	19	57	107	34	-44	-21	-64	-123	-50	-53	42	185	69	47	45	68	179	1,103	1,098	1,101	1,052	122	0	0	0
Income (loss) from discontinued operations, net of tax
2	11	11	10	10	3	4	3	2	0	-1	1	-2	-5	-2	-4	-3	2	-1	-1	-16	-22	-29	-33	-14	-11	-11	4	-47	-44	-53	-65	-2	-10	29	31	6	18	-10	-27	0	0	0
Net income available (loss attributable) to Tenet Healthcare Corporation common shareholders
-127	-232	-232	-9	0	111	-113	-471	-552	-704	-554	-195	-186	-192	-210	-231	-246	-140	18	56	91	12	-73	-54	-78	-134	-61	-49	-5	141	16	-18	43	58	208	1,134	1,104	1,119	1,042	95	0	0	0
Earnings Per Share [Abstract]
Basic
Income (Loss) from Continuing Operations, Per Basic Share
0.90	-0.06	-2.25	0.15	-0.19	-0.05	-0.09	0.23	0.97	-2.29	-3.63	-0.56	-0.52	-0.79	-0.09	-0.44	-0.56	-1.02	-0.28	-0.60	0.47	0.64	0.10	-0.11	-0.28	-0.19	0.33	-0.52	-0.83	0.53	0.29	0.40	0.55	0.27	0.07	0.08	0.16	6.93	1.92	0.07	0.17	0.00	0.01
Discontinued operations (in dollars per share)
-0.01	0.00	0.01	0.02	0.08	0.00	0.00	0.02	0.01	0.01	-0.01	0.01	-0.01	0.00	0.01	-0.02	-0.04	0.03	-0.01	-0.01	0.01	-0.01	-0.01	-0.16	-0.05	-0.07	-0.05	0.03	-0.02	-0.06	0.09	-0.46	0.01	-0.09	-0.02	0.03	-0.01	0.16	0.00	-0.02	0.01	-0.01	-0.04
Total loss per share, Basic (in dollars per share)
0.89	-0.06	-2.24	0.17	-0.11	-0.05	-0.09	0.25	0.98	-2.28	-3.64	-0.55	-0.53	-0.79	-0.08	-0.46	-0.60	-0.99	-0.29	-0.61	0.48	0.63	0.09	-0.27	-0.33	-0.26	0.28	-0.49	-0.85	0.47	0.38	-0.06	0.56	0.18	0.05	0.11	0.15	7.09	1.92	0.05	0.18	-0.01	-0.03
Diluted
Income (Loss) from Continuing Operations, Per Diluted Share
0.89	-0.05	-2.25	0.14	-0.19	-0.05	-0.09	0.23	0.95	-2.29	-3.63	-0.56	-0.52	-0.79	-0.09	-0.44	-0.56	-1.01	-0.28	-0.60	0.46	0.63	0.10	-0.11	-0.28	-0.18	0.32	-0.52	-0.83	0.51	0.28	0.39	0.52	0.26	0.07	0.08	0.15	6.12	1.68	0.07	0.16	0.00	0.01
Discontinued operations (in dollars per share)
-0.01	0.00	0.01	0.02	0.08	0.00	0.00	0.02	0.01	0.01	-0.01	0.01	-0.01	0.00	0.01	-0.02	-0.04	0.03	-0.01	-0.01	0.01	0.00	-0.01	-0.16	-0.05	-0.07	-0.05	0.03	-0.02	-0.05	0.09	-0.45	0.01	-0.08	-0.02	0.03	-0.01	0.14	0.00	-0.02	0.01	-0.01	-0.04
Total loss per share, Diluted (in dollars per share)
0.88	-0.05	-2.24	0.16	-0.11	-0.05	-0.09	0.25	0.96	-2.28	-3.64	-0.55	-0.53	-0.79	-0.08	-0.46	-0.60	-0.98	-0.29	-0.61	0.47	0.63	0.09	-0.27	-0.33	-0.25	0.27	-0.49	-0.85	0.46	0.37	-0.06	0.53	0.18	0.05	0.11	0.14	6.26	1.68	0.05	0.17	-0.01	-0.03
Weighted average shares and dilutive securities outstanding (in thousands):
Weighted Average Number of Shares Outstanding, Basic
104	104	103	103	102	102	102	102	101	100	100	100	100	99	99	99	98	99	99	99	98	98	98	97	97	98	100	103	104	105	104	103	102	-622	117	486	486	-967	485	484	481	481	480
Weighted Average Number of Shares Outstanding, Diluted
105	102	103	104	102	106	102	104	102	100	100	100	100	99	99	99	98	97	99	99	100	105	100	97	97	96	103	103	104	100	107	106	121	-704	120	503	565	-1,060	559	502	559	498	488